Cipla Q4 FY25 results expected to show 9% profit growth, driven by India sales and respiratory portfolio, despite US generic challenges.
12-May-2025•Value Research Team
Adobe Stock
Cipla Ltd is scheduled to report its fourth-quarter results for FY2024-25 (Q4 FY25) on May 13, 2025. Analysts and investors expect a steady performance driven by resilient domestic growth and strong respiratory product momentum, even as the U.S. generics business faces near-term headwinds.
5 most-bought small-cap stocks by mutual funds in May 2025
3 min read•By Ujjal Das and Aditya Gupta
New episodes every Friday
Others' mistakes
The undervalued art of studying investment failures
Other Episodes
It's your life, and your investments
Why trying to invest like the wealthy often backfires spectacularly
Markets defy understanding
Embracing uncertainty might be your best investment strategy
Beyond borders, beyond rules
Investing in foreign stocks is about owning great businesses, not just avoiding domestic market downturns
The vacation test for investments
Something is fundamentally wrong if you can't leave your portfolio alone for a week
Widely read:
